Bighat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Bighat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors, and Gaingels.

San Mateo, CA, USA

BigHat Biosciences

Innovation Endeavors invests in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Innovation Endeavors Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Innovation Endeavors network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Innovation Endeavors company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Investing in visionary founders, transformational technology and emergent ecosystems for a new world.